Secukinumab for ankylosing spondylitis and psoriatic arthritis

Secukinumab for ankylosing spondylitis and psoriatic arthritis

Ennio Lubrano, Fabio Massimo Perrotta Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, Italy Abstract: The treatment of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) positively changed sinc...

Full description

Bibliographic Details
Main Authors: Lubrano E, Perrotta FM
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Therapeutics and Clinical Risk Management
Subjects:
anti IL-17
ankylosing spondylitis
psoriatic arthritis
secukinumab
treatment
Online Access:https://www.dovepress.com/secukinumab-for-ankylosing-spondylitis-and-psoriatic-arthritis-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/secukinumab-for-ankylosing-spondylitis-and-psoriatic-arthritis-peer-reviewed-article-TCRM

Similar Items